These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
206 related articles for article (PubMed ID: 37483735)
1. A novel, effective machine learning-based RNA editing profile for predicting the prognosis of lower-grade gliomas. Wang B; Tian P; Sun Q; Zhang H; Han L; Zhu B Heliyon; 2023 Jul; 9(7):e18075. PubMed ID: 37483735 [TBL] [Abstract][Full Text] [Related]
2. An autophagic gene-based signature to predict the survival of patients with low-grade gliomas. Chen J; Li Y; Han X; Pan Y; Qian X Cancer Med; 2021 Mar; 10(5):1848-1859. PubMed ID: 33591634 [TBL] [Abstract][Full Text] [Related]
3. Machine learning identification of cuproptosis and necroptosis-associated molecular subtypes to aid in prognosis assessment and immunotherapy response prediction in low-grade glioma. Miao Y; Liu J; Liu X; Yuan Q; Li H; Zhang Y; Zhan Y; Feng X Front Genet; 2022; 13():951239. PubMed ID: 36186436 [TBL] [Abstract][Full Text] [Related]
4. Novel Immune-Related Gene Signature for Risk Stratification and Prognosis of Survival in Lower-Grade Glioma. Zhang M; Wang X; Chen X; Zhang Q; Hong J Front Genet; 2020; 11():363. PubMed ID: 32351547 [TBL] [Abstract][Full Text] [Related]
5. A Risk Score Signature Consisting of Six Immune Genes Predicts Overall Survival in Patients with Lower-Grade Gliomas. Wu Y; Peng Z; Gu S; Wang H; Xiang W Comput Math Methods Med; 2022; 2022():2558548. PubMed ID: 35186111 [TBL] [Abstract][Full Text] [Related]
6. Prognostic and Predictive Value of Immune-Related Gene Pair Signature in Primary Lower-Grade Glioma Patients. Lei K; Li J; Tu Z; Liu F; Ye M; Wu M; Zhu Y; Luo M; Lin L; Tao C; Huang K; Zhu X Front Oncol; 2021; 11():665870. PubMed ID: 34123829 [TBL] [Abstract][Full Text] [Related]
7. Comprehensive Characterization of a Novel E3-Related Gene Signature With Implications in Prognosis and Immunotherapy of Low-Grade Gliomas. Tan S; Spear R; Zhao J; Sun X; Wang P Front Genet; 2022; 13():905047. PubMed ID: 35832194 [TBL] [Abstract][Full Text] [Related]
8. DNMT3A promotes glioma growth and malignancy via TNF-α/NF-κB signaling pathway. Su X; Liu J; Tu Z; Ji Q; Li J; Liu F Transl Cancer Res; 2024 Apr; 13(4):1786-1806. PubMed ID: 38737693 [TBL] [Abstract][Full Text] [Related]
9. A Prognostic Microenvironment-Related Immune Signature Qiu H; Li Y; Cheng S; Li J; He C; Li J Front Oncol; 2020; 10():580263. PubMed ID: 33425732 [TBL] [Abstract][Full Text] [Related]
10. Characterization of DNA Damage Repair Related Signature and Molecular Feature in Low-Grade Gliomas to Aid Chemotherapy and Drug Discovery. Yin X; Li M; He Z Front Biosci (Landmark Ed); 2023 Oct; 28(10):234. PubMed ID: 37919061 [TBL] [Abstract][Full Text] [Related]
11. Prognostic Value of a Stemness Index-Associated Signature in Primary Lower-Grade Glioma. Zhang M; Wang X; Chen X; Guo F; Hong J Front Genet; 2020; 11():441. PubMed ID: 32431729 [TBL] [Abstract][Full Text] [Related]
12. N6-methyladenosine RNA methylation regulator-related alternative splicing gene signature as prognostic predictor and in immune microenvironment characterization of patients with low-grade glioma. Maimaiti A; Tuersunniyazi A; Meng X; Pei Y; Ji W; Feng Z; Jiang L; Wang Z; Kasimu M; Wang Y; Shi X Front Genet; 2022; 13():872186. PubMed ID: 35937991 [No Abstract] [Full Text] [Related]
13. A prognostic signature of five pseudogenes for predicting lower-grade gliomas. Liu B; Liu J; Liu K; Huang H; Li Y; Hu X; Wang K; Cao H; Cheng Q Biomed Pharmacother; 2019 Sep; 117():109116. PubMed ID: 31247469 [TBL] [Abstract][Full Text] [Related]
14. Prognostic Model and Nomogram Construction Based on a Novel Ferroptosis-Related Gene Signature in Lower-Grade Glioma. Zhao J; Liu Z; Zheng X; Gao H; Li L Front Genet; 2021; 12():753680. PubMed ID: 34819946 [No Abstract] [Full Text] [Related]
15. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases. Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325 [TBL] [Abstract][Full Text] [Related]
16. A novel prognostic risk score model based on RNA editing level in lower-grade glioma. Jiang B; Chen Z; Zhou J Comput Biol Chem; 2024 Dec; 113():108229. PubMed ID: 39383624 [TBL] [Abstract][Full Text] [Related]
17. Identification and Validation of an Energy Metabolism-Related lncRNA-mRNA Signature for Lower-Grade Glioma. Zhao J; Wang L; Wei B Biomed Res Int; 2020; 2020():3708231. PubMed ID: 32802843 [TBL] [Abstract][Full Text] [Related]
18. Identification and validation of an autophagy-related signature for predicting survival in lower-grade glioma. Feng S; Liu H; Dong X; Du P; Guo H; Pang Q Bioengineered; 2021 Dec; 12(2):9692-9708. PubMed ID: 34696669 [TBL] [Abstract][Full Text] [Related]
19. Establishment and validation of a novel prognostic model for lower-grade glioma based on senescence-related genes. Li J; Wang J; Liu D; Tao C; Zhao J; Wang W Front Immunol; 2022; 13():1018942. PubMed ID: 36341390 [TBL] [Abstract][Full Text] [Related]
20. A Novel Four-Gene Signature Associated With Immune Checkpoint for Predicting Prognosis in Lower-Grade Glioma. Xiao Y; Cui G; Ren X; Hao J; Zhang Y; Yang X; Wang Z; Zhu X; Wang H; Hao C; Duan H Front Oncol; 2020; 10():605737. PubMed ID: 33381460 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]